Psychoactive—and possibly psychedelic in experience

“Psychoactive” means capable of affecting the brain or behavior. By that broad definition, absinthe is psychoactive primarily through ethanol. “Psychedelic” usually refers to a distinct class of drugs whose main effects involve serotonergic 5-HT2A signaling, altered perception, and hallucination. Absinthe has not been established as a classic psychedelic in controlled pharmacology, but that does not erase the possibility that its combined sensory, pharmacological, and ritual effects can be experienced as psychedelic by some drinkers.

Why the absinthe drunk may feel different

One useful model is a simultaneous interaction between ethanol’s broad CNS depression and thujone’s opposing GABAergic excitation. The subjective difference may be the beginning of the “Green Goddess” effect: not one molecule, but a layered shift in attention, arousal, mood, symbolism, and perception.

Absinthe serving Ethanol + variable α-/β-thujone Observed composition varies by product and dose.
→
GABA-A modulation Thujone reduces GABAergic inhibitory currents in receptor studies. Direct in-vitro pharmacology.
→
Net CNS balance Ethanol pushes inhibition; thujone may push excitation. Mechanistically plausible; dose and exposure matter.
→
Different subjective profile Less purely sedating, more alert, tense, or disinhibited. Human study supports attention/mood changes; psychedelic interpretation remains open.

The critical boundary: receptor antagonism can explain excitation, anxiety, impaired attention, or seizure risk. It does not by itself prove a psychedelic mechanism—but neither does one receptor study capture the whole experience of a complex botanical, alcoholic ritual.

Thujone is also metabolized

α-Thujone Exact chemical identity; α and β are distinct diastereomers.
→
CYP2A6 oxidation Major 4- and 7-hydroxylation in human liver preparations; CYP3A4 and CYP2B6 contribute. Direct in-vitro human-liver evidence.
→
Hydroxythujones / conjugates Human urine studies detect 4- and 7-hydroxythujone after conjugate release. Clearance is supported; contribution to the “different drunk” is unestablished.

This is a metabolism pathway, not proof of a psychoactive metabolite. The available work supports biotransformation and detoxification, while the human dose–concentration–effect relationship remains uncertain.

What each constituent contributes

ConstituentEvidence-based interpretation
EthanolThe dominant intoxicant: disinhibition, sedation, impaired judgment, memory effects, and dose-dependent poisoning risk.
α-/β-ThujoneNeuroactive monoterpene ketones; GABA-A modulation may add lift, tension, vividness, or instability. High exposure can produce seizures.
trans-AnetholeMajor anise/fennel aroma compound with preclinical CNS activity; its contribution may be subtle, sensory, or synergistic rather than a standalone “trip.”
Fenchone / camphorNeuroactive monoterpene ketones that may sharpen the profile at low levels but become toxic and convulsant when concentrated.
Pinocamphone / isopinocamphoneHyssop constituents that can alter the aromatic and bodily character; concentrated essential oils carry seizure risk.

Why absinthe became “psychedelic” in popular memory

The old reputation likely combines very high alcohol intake, chronic heavy use, sleep loss, malnutrition, withdrawal, variable or adulterated products, and the mythology of nineteenth-century bohemia. Historical claims of extremely high thujone concentrations have not been reliably confirmed in modern analyses.

A controlled human study found that a high-thujone drink impaired attention and partly counteracted alcohol’s anxiolytic effect. It was not designed to capture the full symbolic, sensory, or psychedelic dimensions of absinthe experience.